Navigating the market for this new medication and the GLP-1 receptor agonist in the UK can be difficult. Currently, access through the NHS is limited , meaning many patients are pursuing non-NHS pathways https://buytirzepatides.co.uk/product/buy-alluvi-tirzepatide-40mg-rd-peptide-uk/